Tina Flatau

Director/Board Member at Sixfold Bioscience, Inc.

Commercial Services

Health Technology

Profile

Tina Flatau is currently a Director at Sixfold Bioscience, Inc. She previously worked as the Managing Director at MedAnnex Ltd.
and as the Vice President-Alliances & Project Management at Prosensa Holding NV.

Tina Flatau active positions

Companies	Position	Start
Sixfold Bioscience, Inc. Sixfold Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sixfold Bioscience Ltd., Sixfold Bioscience, Inc. operates as a biotechnology company that develops next-generation in vivo delivery systems for RNA therapeutics. The company is based in Walnut, CA.	Director/Board Member	-

All active positions of Tina Flatau

Former positions of Tina Flatau

Companies	Position	End
MedAnnex Ltd. MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services MedAnnex Ltd. operates preclinical-stage biotechnology company. It develops approaches to treating autoimmune diseases and other medical conditions. The company was founded by Christopher Barry Wood and Hugh Stephen Griffith in 2009 and is headquartered in Edinburgh, the United Kingdom.	Chief Executive Officer	2019-02-28
PROSENSA HOLDING NV	Corporate Officer/Principal	-

See the detail of Tina Flatau's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Tina Flatau's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Prosensa Holding NV Prosensa Holding NV BiotechnologyHealth Technology Prosensa Holding NV engages in the development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The company focuses on rare neuromuscular and neurodegenerative disorders, Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease. It has developed a portfolio of clinical and pre-clinical RNA-based drug candidates. Prosensa's current clinical portfolio is focused on the treatment of Duchenne Muscular Dystrophy. The company was founded in 2002 and is headquartered in Leiden, the Netherlands.	Health Technology
MedAnnex Ltd. MedAnnex Ltd. Miscellaneous Commercial ServicesCommercial Services MedAnnex Ltd. operates preclinical-stage biotechnology company. It develops approaches to treating autoimmune diseases and other medical conditions. The company was founded by Christopher Barry Wood and Hugh Stephen Griffith in 2009 and is headquartered in Edinburgh, the United Kingdom.	Commercial Services
Sixfold Bioscience, Inc. Sixfold Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sixfold Bioscience Ltd., Sixfold Bioscience, Inc. operates as a biotechnology company that develops next-generation in vivo delivery systems for RNA therapeutics. The company is based in Walnut, CA.	Commercial Services

See company connections